Department of Pediatrics, University of California San Diego, La Jolla, CA.
Department of Biochemistry, Fraternal Order of Eagles Diabetes Research Center, Obesity Research and Education Initiative, University of Iowa Carver College of Medicine, Iowa City, IA.
Diabetes. 2020 Jun;69(6):1100-1109. doi: 10.2337/db19-1181. Epub 2020 Feb 12.
To ensure fetal lipid supply, maternal blood triglyceride (TG) concentrations are robustly elevated during pregnancy. Interestingly, a lower increase in maternal blood TG concentrations has been observed in some obese mothers. We have shown that high-fat (HF) feeding during pregnancy significantly reduces maternal blood TG levels. Therefore, we performed this study to investigate if and how obesity alters maternal blood TG levels. Maternal obesity was established by prepregnant HF (ppHF) feeding, which avoided the dietary effect during pregnancy. We found not only that maternal blood TG concentrations in ppHF dams were remarkably lower than in control dams but also that the TG peak occurred earlier during gestation. Hepatic TG production and intestinal TG absorption were unchanged in ppHF dams, but systemic lipoprotein lipase (LPL) activity was increased, suggesting that increased blood TG clearance contributes to the decreased blood TG concentrations in ppHF dams. Although significantly higher levels of UCP1 protein were observed in interscapular brown adipose tissue (iBAT) of ppHF dams, gene deletion did not restore blood TG concentrations in ppHF dams. Expression of the angiopoietin-like protein 4 (ANGPTL4), a potent endogenous LPL inhibitor, was significantly increased during pregnancy. However, the pregnancy-induced elevation of blood TG was almost abolished in dams. Compared with control dams, mRNA levels were significantly lower in iBAT, gonadal white adipose tissue, and livers of ppHF dams. Importantly, ectopic overexpression of ANGPTL4 restored maternal blood TG concentrations in ppHF dams. Together, these results indicate that ANGPTL4 plays a vital role in increasing maternal blood TG concentrations during pregnancy. Obesity impairs the rise of maternal blood TG concentrations by reducing ANGPTL4 expression in mice.
为了确保胎儿的脂质供应,母体血液中的甘油三酯 (TG) 浓度在怀孕期间会显著升高。有趣的是,一些肥胖母亲的母体血液 TG 浓度增加较低。我们已经表明,怀孕期间高脂肪 (HF) 喂养会显著降低母体血液 TG 水平。因此,我们进行了这项研究,以调查肥胖是否以及如何改变母体血液 TG 水平。母体肥胖是通过孕前 HF(ppHF)喂养建立的,这避免了怀孕期间的饮食影响。我们不仅发现 ppHF 母鼠的母体血液 TG 浓度明显低于对照母鼠,而且 TG 峰值在妊娠期间更早出现。ppHF 母鼠的肝 TG 生成和肠 TG 吸收没有改变,但全身脂蛋白脂肪酶 (LPL) 活性增加,表明增加的血液 TG 清除有助于降低 ppHF 母鼠的血液 TG 浓度。尽管 ppHF 母鼠的肩胛间棕色脂肪组织 (iBAT) 中观察到 UCP1 蛋白水平显著升高,但基因缺失并未恢复 ppHF 母鼠的血液 TG 浓度。血管生成素样蛋白 4 (ANGPTL4) 的表达显著增加,ANGPTL4 是一种有效的内源性 LPL 抑制剂。然而,在 母鼠中,妊娠引起的血液 TG 升高几乎被消除。与对照母鼠相比,ppHF 母鼠的 iBAT、性腺白色脂肪组织和肝脏中的 mRNA 水平显著降低。重要的是,ANGPTL4 的异位过表达恢复了 ppHF 母鼠的母体血液 TG 浓度。这些结果表明,ANGPTL4 在增加母体血液 TG 浓度方面在怀孕期间起着至关重要的作用。肥胖通过降低小鼠中 ANGPTL4 的表达来损害母体血液 TG 浓度的升高。